Product Information
ACETAMINOPHEN 160 MG/5 ML SOLN is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0107 per ML under NDC 57237030416. Its NADAC has been published 147 times since Dec 13, 2023.
Strength
160 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237030416
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013.50On Market Since
8/10/2023
Price Statistics
The NADAC for ACETAMINOPHEN 160 MG/5 ML SOLN has been published 147 times since Dec 13, 2023, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0107 per ML |
|---|---|
| All-time high | $0.0146 (Sep 10, 2025) |
| All-time low | $0.0080 (Jan 17, 2024) |
| 52-week high | $0.0143 |
| 52-week low | $0.0107 |
| Median price | $0.0115 |
| Average price | $0.0118 |
| Largest weekly change | +70.1% (Feb 21, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 160 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 160 MG/5 ML SOLN, manufactured by Rising Pharma Holdings Inc., is $0.0107 per ML (NDC 57237030416), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN 160 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 160 MG/5 ML SOLN has risen 3.3%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 160 MG/5 ML SOLN?
Since Dec 13, 2023, the NADAC for ACETAMINOPHEN 160 MG/5 ML SOLN has ranged from a low of $0.0080 (Jan 17, 2024) to a high of $0.0146 (Sep 10, 2025), with a median of $0.0115 per ML.
Are there cheaper alternatives to ACETAMINOPHEN 160 MG/5 ML SOLN?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACETAMINOPHEN 160 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures ACETAMINOPHEN 160 MG/5 ML SOLN?
ACETAMINOPHEN 160 MG/5 ML SOLN (NDC 57237030416) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.